ATIF IQBAL to Rectal Neoplasms
This is a "connection" page, showing publications ATIF IQBAL has written about Rectal Neoplasms.
Connection Strength
2.399
-
Validation of a pelvic surgery difficulty risk model to predict difficult pelvic dissection and poor outcomes. Surgery. 2023 05; 173(5):1199-1204.
Score: 0.473
-
A Comprehensive Review of Randomized Clinical Trials Shaping the Landscape of Rectal Cancer Therapy. Clin Colorectal Cancer. 2021 03; 20(1):1-19.
Score: 0.397
-
Rectal cancer patients younger than 50 years lack a survival benefit from NCCN guideline-directed treatment for stage II and III disease. Cancer. 2018 09 01; 124(17):3510-3519.
Score: 0.344
-
Objective Preoperative Parameters Predict Difficult Pelvic Dissections and Clinical Outcomes. J Surg Res. 2018 12; 232:15-25.
Score: 0.343
-
Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy. J Natl Cancer Inst. 2018 05 01; 110(5):460-466.
Score: 0.339
-
Randomized Clinical Trials in Colon and Rectal Cancer. Surg Oncol Clin N Am. 2017 10; 26(4):689-704.
Score: 0.323
-
ctDNA applications and integration in colorectal cancer: an NCI Colon and Rectal-Anal Task Forces whitepaper. Nat Rev Clin Oncol. 2020 12; 17(12):757-770.
Score: 0.099
-
Total Neoadjuvant Therapy: A Shifting Paradigm in Locally Advanced Rectal Cancer Management. Clin Colorectal Cancer. 2018 03; 17(1):1-12.
Score: 0.080